-
1
-
-
0028288398
-
Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA
-
Roth M.P., Nogueira L., Coppin H., Clanet M., Clayton J., and Cambon-Thomsen A. Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 51 (1994) 93-99
-
(1994)
J Neuroimmunol
, vol.51
, pp. 93-99
-
-
Roth, M.P.1
Nogueira, L.2
Coppin, H.3
Clanet, M.4
Clayton, J.5
Cambon-Thomsen, A.6
-
2
-
-
0035674613
-
Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritis
-
Mohan N., Edwards E.T., Cupps T.R., Oliverio P.J., Sandberg G., Crayton H., et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritis. Arthritis Rheum 44 (2001) 2862-2869
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2862-2869
-
-
Mohan, N.1
Edwards, E.T.2
Cupps, T.R.3
Oliverio, P.J.4
Sandberg, G.5
Crayton, H.6
-
3
-
-
0035960624
-
Onset of multiple sclerosis associated with anti-TNF therapy
-
Sicotte N.L., and Voskuhl R.R. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57 (2001) 1885-1888
-
(2001)
Neurology
, vol.57
, pp. 1885-1888
-
-
Sicotte, N.L.1
Voskuhl, R.R.2
-
4
-
-
0033546665
-
-
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1999;53: 457-65.
-
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1999;53: 457-65.
-
-
-
-
5
-
-
0030832846
-
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
-
Barkhof F., Filippi M., Miller D.H., Scheltens P., Campi A., Polman C.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (1997) 2059-2069
-
(1997)
Brain
, vol.120
, pp. 2059-2069
-
-
Barkhof, F.1
Filippi, M.2
Miller, D.H.3
Scheltens, P.4
Campi, A.5
Polman, C.H.6
-
6
-
-
28544436950
-
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"
-
Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58 (2005) 840-846
-
(2005)
Ann Neurol
, vol.58
, pp. 840-846
-
-
Polman, C.H.1
Reingold, S.C.2
Edan, G.3
Filippi, M.4
Hartung, H.P.5
Kappos, L.6
-
8
-
-
0038109994
-
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study
-
Vermeire S., Noman M., Van Assche G., Baert F., Van Steen K., Esters N., et al. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology 125 (2003) 32-39
-
(2003)
Gastroenterology
, vol.125
, pp. 32-39
-
-
Vermeire, S.1
Noman, M.2
Van Assche, G.3
Baert, F.4
Van Steen, K.5
Esters, N.6
-
9
-
-
14844293983
-
Optic neuritis associated with infliximab
-
Tran T.H., Milea D., Cassoux N., Bodaghi B., Bourgeois P., and LeHoang P. Optic neuritis associated with infliximab. J Fr Ophtalmol 28 (2005) 201-204
-
(2005)
J Fr Ophtalmol
, vol.28
, pp. 201-204
-
-
Tran, T.H.1
Milea, D.2
Cassoux, N.3
Bodaghi, B.4
Bourgeois, P.5
LeHoang, P.6
-
10
-
-
34447505845
-
Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases
-
Ramos-Casals M., Brito-Zeron P., Munoz S., Soria N., Galiana D., Bertolaccini L., et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86 (2007) 242-251
-
(2007)
Medicine (Baltimore)
, vol.86
, pp. 242-251
-
-
Ramos-Casals, M.1
Brito-Zeron, P.2
Munoz, S.3
Soria, N.4
Galiana, D.5
Bertolaccini, L.6
-
11
-
-
33644774314
-
Optic neuritis associated with etanercept therapy for juvenile arthritis
-
Tauber T., Turetz J., Barash J., Avni I., and Morad Y. Optic neuritis associated with etanercept therapy for juvenile arthritis. J AAPOS 10 (2006) 26-29
-
(2006)
J AAPOS
, vol.10
, pp. 26-29
-
-
Tauber, T.1
Turetz, J.2
Barash, J.3
Avni, I.4
Morad, Y.5
-
12
-
-
32944477248
-
Anti-tumor necrosis factor alpha-associated multiple sclerosis
-
Titelbaum D.S., Degenhardt A., and Kinkel R.P. Anti-tumor necrosis factor alpha-associated multiple sclerosis. AJNR Am J Neuroradiol 26 (2005) 1548-1550
-
(2005)
AJNR Am J Neuroradiol
, vol.26
, pp. 1548-1550
-
-
Titelbaum, D.S.1
Degenhardt, A.2
Kinkel, R.P.3
-
13
-
-
0025852567
-
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
-
Selmaj K., Raine C.S., Cannella B., and Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87 (1991) 949-954
-
(1991)
J Clin Invest
, vol.87
, pp. 949-954
-
-
Selmaj, K.1
Raine, C.S.2
Cannella, B.3
Brosnan, C.F.4
-
14
-
-
0029316962
-
Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors
-
Selmaj K.W., and Raine C.S. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45 (1995) S44-S49
-
(1995)
Neurology
, vol.45
-
-
Selmaj, K.W.1
Raine, C.S.2
-
15
-
-
0025773147
-
Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis
-
Sharief M.K., and Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325 (1991) 467-472
-
(1991)
N Engl J Med
, vol.325
, pp. 467-472
-
-
Sharief, M.K.1
Hentges, R.2
-
16
-
-
0035464263
-
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
-
Robinson W.H., Genovese M.C., and Moreland L.W. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?. Arthritis Rheum 44 (2001) 1977-1983
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1977-1983
-
-
Robinson, W.H.1
Genovese, M.C.2
Moreland, L.W.3
-
17
-
-
0029751983
-
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
-
van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., von Blomberg B.M., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47 (1996) 1531-1534
-
(1996)
Neurology
, vol.47
, pp. 1531-1534
-
-
van Oosten, B.W.1
Barkhof, F.2
Truyen, L.3
Boringa, J.B.4
Bertelsmann, F.W.5
von Blomberg, B.M.6
-
18
-
-
14944382276
-
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha
-
Mitoma H., Horiuchi T., Hatta N., Tsukamoto H., Harashima S., Kikuchi Y., et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 128i (2005) 376-392
-
(2005)
Gastroenterology
, vol.128 i
, pp. 376-392
-
-
Mitoma, H.1
Horiuchi, T.2
Hatta, N.3
Tsukamoto, H.4
Harashima, S.5
Kikuchi, Y.6
-
19
-
-
0029112253
-
Induction of apoptosis in mature T-cells by tumour necrosis factor
-
Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., and Lenardo M.J. Induction of apoptosis in mature T-cells by tumour necrosis factor. Nature 377 (1995) 348-351
-
(1995)
Nature
, vol.377
, pp. 348-351
-
-
Zheng, L.1
Fisher, G.2
Miller, R.E.3
Peschon, J.4
Lynch, D.H.5
Lenardo, M.J.6
-
20
-
-
0030178426
-
Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis?
-
Hohlfeld R. Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis?. Mult Scler 1 (1996) 376-378
-
(1996)
Mult Scler
, vol.1
, pp. 376-378
-
-
Hohlfeld, R.1
-
21
-
-
0023221133
-
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system
-
Panitch H.S., Hirsch R.L., Schindler J., and Johnson K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37 (1987) 1097-1102
-
(1987)
Neurology
, vol.37
, pp. 1097-1102
-
-
Panitch, H.S.1
Hirsch, R.L.2
Schindler, J.3
Johnson, K.P.4
-
22
-
-
0030769165
-
The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire
-
Cope A., Ettinger R., and McDevitt H. The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol 148 (1997) 307-312
-
(1997)
Res Immunol
, vol.148
, pp. 307-312
-
-
Cope, A.1
Ettinger, R.2
McDevitt, H.3
-
23
-
-
37849052961
-
TNF alpha blockade in human diseases: Mechanisms and future directions
-
Wong M., Ziring D., Korin Y., Desai S., Kim S., Lin J., Gjertson D., Braun J., Reed E., and Singh R.R. TNF alpha blockade in human diseases: Mechanisms and future directions. Clin Immunol 126 (2008) 121-136
-
(2008)
Clin Immunol
, vol.126
, pp. 121-136
-
-
Wong, M.1
Ziring, D.2
Korin, Y.3
Desai, S.4
Kim, S.5
Lin, J.6
Gjertson, D.7
Braun, J.8
Reed, E.9
Singh, R.R.10
-
24
-
-
0031579677
-
Tumour necrosis factor microsatellites show association with multiple sclerosis
-
Kirk C.W., Droogan A.G., Hawkins S.A., McMillan S.A., Nevin N.C., and Graham C.A. Tumour necrosis factor microsatellites show association with multiple sclerosis. J Neurol Sci 147 (1997) 21-25
-
(1997)
J Neurol Sci
, vol.147
, pp. 21-25
-
-
Kirk, C.W.1
Droogan, A.G.2
Hawkins, S.A.3
McMillan, S.A.4
Nevin, N.C.5
Graham, C.A.6
-
25
-
-
38049115514
-
Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature
-
Hamon M.A., Nicolas G., Deviere F., Letournel F., and Dubas F. Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature. Rev Neurol (Paris) 163 (2007) 1232-1235
-
(2007)
Rev Neurol (Paris)
, vol.163
, pp. 1232-1235
-
-
Hamon, M.A.1
Nicolas, G.2
Deviere, F.3
Letournel, F.4
Dubas, F.5
-
26
-
-
50449086014
-
Relapsing demyelinating disease affecting both the central and peripheral nervous systems
-
Zephir H., Stojkovic T., Latour P., Lacour A., de Seze J., Outteryck O., Maurage C.A., Monpeurt C., Chatelet P., Ovelacq E., and Vermersch P. Relapsing demyelinating disease affecting both the central and peripheral nervous systems. J Neurol Neurosurg Psychiatry 79 (2008) 1032-1039
-
(2008)
J Neurol Neurosurg Psychiatry
, vol.79
, pp. 1032-1039
-
-
Zephir, H.1
Stojkovic, T.2
Latour, P.3
Lacour, A.4
de Seze, J.5
Outteryck, O.6
Maurage, C.A.7
Monpeurt, C.8
Chatelet, P.9
Ovelacq, E.10
Vermersch, P.11
|